Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway

INTRODUCTION: The objective of this work was to evaluate the efficacy of placenta-derived mesenchymal stem cell (MSC) therapy in a mouse model of myocardial infarction (MI). Since MSCs can be obtained from two different regions of the human term placenta (chorionic plate or villi), cells obtained fr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Stem Cell Res Ther
Auteurs principaux: Passipieri, Juliana A, Kasai-Brunswick, Tais H, Suhett, Grazielle, Martins, Andreza B, Brasil, Guilherme V, Campos, Dilza B, Rocha, Nazareth N, Ramos, Isalira P, Mello, Debora B, Rodrigues, Deivid C, Christie, Beatriz B, Silva-Mendes, Bernardo J, Balduíno, Alex, Sá, Renato M, Lopes, Laudelino M, Goldenberg, Regina C, Campos de Carvalho, Antonio C, Carvalho, Adriana B
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354978/
https://ncbi.nlm.nih.gov/pubmed/25145631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt490
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires